Kivu Bioscience
4 known investors
Kivu Bioscience is a biotechnology company developing next-generation antibody-drug conjugates (ADCs) for oncology, using site-specific conjugation technology to create more stable and homogeneous cancer therapies with reduced off-tumor toxicity. Its pipeline of ADC candidates targets solid tumors and other cancer indications.
BiotechDeep TechHealthtech
Founders & leadership
MT
Mohit TrikhaCEO
Investors · 4
Frequently asked questions
- What does Kivu Bioscience do?
- Kivu Bioscience is a biotechnology company developing next-generation antibody-drug conjugates (ADCs) for oncology, using site-specific conjugation technology to create more stable and homogeneous cancer therapies with reduced off-tumor toxicity. Its pipeline of ADC candidates targets solid tumors and other cancer indications.
- Who are Kivu Bioscience's investors?
- Kivu Bioscience's investors include BOM, HealthCap, Red Tree Venture, M Ventures.